Product details
Catalog number BNUM1761-50
Price for BNUM1761-50
Size / count 1x 50 µL
This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), 1mg/mL is BNUM1761-50.
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), 1mg/mL is available in the following size(s): 1x 50 µL.
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), 1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), 1mg/mL is manufactured by Biotium.
Estimated delivery time for MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), 1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), 1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.
This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized b
Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.
Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.
Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.